Macro Group Pharmaceuticals (Macro Capital) S.A.E

CASE:MCRO Stock Report

Market Cap: ج.م707.1m

Macro Group Pharmaceuticals (Macro Capital)E Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Khaled Kamel

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure5.4yrs

Recent management updates

Recent updates

CEO

Khaled Kamel

no data
Tenure

Mr. Khaled Kamel is Managing Director Chief Executive Officer of Macro Group Pharmaceuticals (Macro Capital) S.A.E. Mr. Kamel is a Group CFO for El Sewedy Industries group. Before assuming his current role...

Board Members

NamePositionTenureCompensationOwnership
Sahar El Sallab
Non Executive Independent Director5.4yrsno datano data
Ahmed Badreldin
Non Executive Director5.4yrsno datano data
Tamer Saeed
Non Executive Director5.4yrsno datano data
Ahmed Nayeb
Non Executive Chairman5.4yrsno data0.000090%
EGP 636.4
Ahmed Rady
Non-Executive Vice Chairman5.4yrsno datano data
Norbert Lurz
Non-Executive Director5.4yrsno datano data
Samia El Baroudy
Non Executive Independent Director5.4yrsno datano data
Conor McNaughton
Non-Executive Director5.4yrsno datano data
5.4yrs
Average Tenure
50yo
Average Age

Experienced Board: MCRO's board of directors are considered experienced (5.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/20 14:27
End of Day Share Price 2026/06/17 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Macro Group Pharmaceuticals (Macro Capital) S.A.E is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.